Skip to main content

PerkinElmer Declares $.07 Quarterly Dividend

NEW YORK, Jan. 25 (GenomeWeb News) - PerkinElmer's board of directors has approved a regular quarterly dividend of $.07 cents per share of common stock, the company said yesterday.


The dividend is payable on May 12, 2006, to shareholders of record at the close of business on April 21, 2006, the company said.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.